Yan Kong

Prevalence of BRAF V600E mutation in Chinese melanoma patients: Large scale analysis of BRAF and NRAS mutations in a 432-case cohort

Lu Si, Yan Kong, Xiaowei Xu et al. · European Journal of Cancer · 2011 · 265 citations

Medicine, Genetics, Oncology +15

The NKG2D ligand ULBP4 binds to TCRγ9/δ2 and induces cytotoxicity to tumor cells through both TCRγδ and NKG2D

Yan Kong, Wei Cao, Xueyan Xi et al. · Blood · 2009 · 163 citations · Full text

Life Sciences, Immunology, Molecular Biology +16

<i>MAPK</i> Pathway and <i>TERT</i> Promoter Gene Mutation Pattern and Its Prognostic Value in Melanoma Patients: A Retrospective Study of 2,793 Cases

Xue Bai, Yan Kong, Zhihong Chi et al. · Clinical Cancer Research · 2017 · 114 citations

Medicine, Molecular Genetics, Oncology +17

STAT3/p53 pathway activation disrupts IFN-β–induced dormancy in tumor-repopulating cells

Yuying Liu, Jiadi Lv, Jinyan Liu et al. · Journal of Clinical Investigation · 2018 · 104 citations · Full text

Life Sciences, Immunology, Oncology +17

Analysis of <i>mTOR</i> Gene Aberrations in Melanoma Patients and Evaluation of Their Sensitivity to PI3K–AKT–mTOR Pathway Inhibitors

Yan Kong, Lu Si, Yiqian Li et al. · Clinical Cancer Research · 2015 · 83 citations

Medicine, Molecular Genetics, Oncology +17